alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › polypeptide-receptor

polypeptide-receptor

3 studies tagged polypeptide-receptor, dated 2018-06-22 to 2025-02-18. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders 2025-02-18
  2. Disbalance of the Duodenal Epithelial Cell Turnover and Apoptosis Accompanies Insensitivity of Intestinal Redox Homeostasis to Inhibition of the Brain Glucose-Dependent Insulinotropic Polypeptide Receptors in a Rat Model of Sporadic Alzheimer's Disease 2021-10-04
  3. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders 2018-06-22

Studies

3 studies carry this tag.

Date range

2018 to 2025

Top journals

  • CNS spectrums 1
  • Expert opinion on therapeutic targets 1
  • Neuroendocrinology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. CNS spectrums 2025-02-18 Drug development

    Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (RAs) mimic naturally occurring GLP-1 and GIP and are highly effective anti-diabetic and anti-obesity agents.

  2. Disbalance of the Duodenal Epithelial Cell Turnover and Apoptosis Accompanies Insensitivity of Intestinal Redox Homeostasis to Inhibition of the Brain Glucose-Dependent Insulinotropic Polypeptide Receptors in a Rat Model of Sporadic Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Neuroendocrinology 2021-10-04 Drug development

    Brain GIP-R seems to be involved in the regulation of duodenal redox homeostasis and epithelial cell turnover.

  3. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Expert opinion on therapeutic targets 2018-06-22 Drug development

    Incretin hormones, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) exert pleiotropic effects on endocrine pancreas and nervous system.

All topic tags with their study counts